With antimicrobial resistance rising as one of the world's most pressing health threats, the 8th World Congress on Targeting ...

This important study analyzes the effect of heat treatment on phage-bacterial interactions and convincingly shows that prior heat exposure alters the bacterial cell envelope, enhancing persistence and ...

Biomx Inc., a company specializing in phage therapy, presented its first-quarter earnings call for 2025, highlighting significant progress in its clinical trials and strategic initiatives.

BX211 was safe and well-toleratedBX211 produced sustained and statistically significant1 Percent Area Reduction (PAR) of ulcer size (p = 0.046 at ...

so their widespread prevalence makes them a promising target for developing strategies to bolster the effectiveness of phage therapy. "If we target phage defense systems present in bacteria to ...

BiomX's BX211 virus therapy shows promise in Phase 2 trial, reducing foot ulcer size in diabetic bone infection patients ...

Although the advent and mass production of antibiotics caused a decline in phage therapy, the recent rise in antibiotic resistance has renewed the global interest in this line of treatment. In this ...

is the first dedicated phage therapy center in North America focusing on medical solutions to combat antibiotic resistant infections. Because most phages simply inject their DNA directly into the ...

In a growing global trend, bacteria have evolved new ways to maneuver around medical treatments for a variety of infections. The rising antibiotic resistance crisis poses a significant public health ...

Nonetheless, there are several challenges that must be addressed prior to widespread adoption of phage therapy. In this section, the authors consider various strategies of phage formulation ...